COMPARATIVE STUDY
JOURNAL ARTICLE
RANDOMIZED CONTROLLED TRIAL
RESEARCH SUPPORT, NON-U.S. GOV'T
A Comparison of 2 Ultrasound-Guided Approaches to the Saphenous Nerve Block: Adductor Canal Versus Distal Transsartorial: A Prospective, Randomized, Blinded, Noninferiority Trial.
Regional Anesthesia and Pain Medicine 2015 September
BACKGROUND AND OBJECTIVES: Saphenous nerve blocks can be technically challenging. Recently described ultrasound techniques have improved the success rate of saphenous nerve blocks, but randomized controlled trials comparing these ultrasound-guided techniques are lacking. We compared 2 common ultrasound-guided approaches for saphenous nerve block: saphenous nerve block at the adductor canal (ACSNB) versus block by the distal transsartorial (DTSNB) approach.
METHODS: Patients received either ACSNB or DTSNB in this prospective, randomized, blinded, noninferiority clinical trial. The primary objective was to show the noninferiority of ACSNB to DTSNB in terms of block success. Secondary outcome measures were time required to perform the block, time to onset of successful block, and the visibility of the nerve using ultrasound.
RESULTS: One hundred twenty patients were randomized to receive DTSNB (n = 62) or ACSNB (n = 58). There were 9 failures in the DTSNB group (85% success) and no failures in the ACSNB group (100% success), 90% confidence interval of difference in success rates (DTSNB - ACSNB) was -0.195 to -0.031. Given that the upper confidence bound (-3.1%) was less than 10%, the success rate of ACSNB was noninferior to DTSNB. After satisfying noninferiority and observing a greater success rate of ACSNB compared with DTSNB, we also determined that ACSNB was superior to DTSNB (P = 0.003). The median time to success was significantly less for the ACSNB group: 9 minutes versus 3 minutes (P < 0.001). The grade of the ultrasound image, as judged by the provider, was significantly better in the ACSNB group (P = 0.001).
CONCLUSIONS: Ultrasound-guided block of the saphenous nerve at the adductor canal is not only noninferior but also superior to block at the distal transsartorial level in terms of success rate, with additional advantages of faster block onset time and better nerve visibility under ultrasound.
METHODS: Patients received either ACSNB or DTSNB in this prospective, randomized, blinded, noninferiority clinical trial. The primary objective was to show the noninferiority of ACSNB to DTSNB in terms of block success. Secondary outcome measures were time required to perform the block, time to onset of successful block, and the visibility of the nerve using ultrasound.
RESULTS: One hundred twenty patients were randomized to receive DTSNB (n = 62) or ACSNB (n = 58). There were 9 failures in the DTSNB group (85% success) and no failures in the ACSNB group (100% success), 90% confidence interval of difference in success rates (DTSNB - ACSNB) was -0.195 to -0.031. Given that the upper confidence bound (-3.1%) was less than 10%, the success rate of ACSNB was noninferior to DTSNB. After satisfying noninferiority and observing a greater success rate of ACSNB compared with DTSNB, we also determined that ACSNB was superior to DTSNB (P = 0.003). The median time to success was significantly less for the ACSNB group: 9 minutes versus 3 minutes (P < 0.001). The grade of the ultrasound image, as judged by the provider, was significantly better in the ACSNB group (P = 0.001).
CONCLUSIONS: Ultrasound-guided block of the saphenous nerve at the adductor canal is not only noninferior but also superior to block at the distal transsartorial level in terms of success rate, with additional advantages of faster block onset time and better nerve visibility under ultrasound.
Full text links
Trending Papers
Carvedilol, probably the β-blocker of choice for everyone with cirrhosis and portal hypertension: But not so fast!Liver International : Official Journal of the International Association for the Study of the Liver 2023 June
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis.Nature Reviews. Rheumatology 2023 May 10
Advances in Acute Ischemic Stroke Treatment: Current Status and Future Directions.AJNR. American Journal of Neuroradiology 2023 May 19
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app